The human epidermal growth factor receptor 2 (HER2) is a well-established oncogenic
driver and a successful therapeutic target in several malignancies, such as breast and …

Numerous inherent and acquired genetic alterations have been demonstrated with
resistance to anti-epidermal growth factor receptor (anti-EGFR) therapy in metastatic …

Background To evaluate the diagnostic accuracy of single gastroscopy, multi-slice spiral CT,
HER-2 or tumor markers, and their combination in the diagnosis of gastric cancer. Methods …

Simple Summary Human epidermal growth factor receptors (HERs) are present in our body
and are responsible for regulating cell growth. When there is an overexpression of …

Although the positivity of human epidermal growth factor receptor 2 (HER2) is low in
colorectal cancer (CRC), anti-HER2 is becoming a new target therapy in metastatic …

Objective Although HER2 has gradually become an important therapeutic target for
colorectal cancer (CRC), a unified and standard HER2 scoring system was still not …

The status of human epidermal growth factor receptor 2 (HER2) for the prognosis in
colorectal cancer (CRC) is controversial, and the characteristics of the somatic mutation …

Objective: This study aimed to evaluate the expression of Beclin 1 and HER2 proteins using
immunohistochemistry in CRC tissues compared to colonic adenoma, and to investigate the …

Background In metastatic colorectal cancer (mCRC), the prognostic relevance of the human
epidermal growth factor receptor-2 (HER2) remains controversial. We evaluated the impact …

Background: Colorectal cancer (CRC) is a major public health problem and one of leading
cancer related death all over the world. One of the prognostic parameters that play a role in …